Información del producto
Nombre:Fruquintinib
Marca:Biosynth
Descripción:Fruquintinib is an investigational drug that targets the cell signaling pathways involved in the progression of metastatic colorectal cancer and leukemia. It has been shown to inhibit the body's production of malonic acid, which is a precursor in the synthesis of collagen. Fruquintinib also inhibits choroidal neovascularization, a condition that can lead to blindness. The drug has been evaluated as a treatment option for renal cell cancer and malignant melanoma, with promising results. Fruquintinib binds to proteins in the blood and reaches its highest concentrations in plasma after one hour. The drug does not bind well to proteins in the gastrointestinal tract, which means that it is only minimally absorbed from this site of administration. Fruquintinib is metabolized extensively by cytochrome P450 enzymes and glucuronidases (UGTs) into metabolites that are excreted via urine and bile.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:393.39 g/mol
Fórmula:C21H19N3O5
Pureza:Min. 95%
Consulta técnica sobre: Fruquintinib
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.